ARWR - Arrowhead Pharmaceuticals Q1 2023 Earnings Preview

• Arrowhead Pharmaceuticals ( NASDAQ: ARWR ) is scheduled to announce Q1 earnings results on Monday, February 6th, after market close.
• The consensus EPS Estimate is $0.13 and the consensus Revenue Estimate is $174.02M (+535.1% Y/Y).
• Over the last 1 year, ARWR has beaten EPS estimates 25% of the time and has beaten revenue estimates 25% of the time.
• Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 2 downward.

For further details see: